Pharmaceutical giant’s boss says 2020 deadline possible if regulators move fast
- Coronavirus – latest updates
- See all our coronavirus coverage
AstraZeneca’s chief executive Pascal Soriot said the company’s coronavirus vaccine could still be available by the end of the year, or early next year, despite having to pause clinical trials after a volunteer fell ill.
AstraZeneca and the University of Oxford, which are jointly developing the vaccine and testing it on 50,000 people around the world, have had to halt trials of their vaccine to investigate the “potentially unexpected illness” of one volunteer.
